ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights
November 12, 2024 01:30 ET
|
ONWARD Medical NV
ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights
Evaxion to announce business update and third quarter 2024 financial results on October 31
October 28, 2024 08:00 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, October 28, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a...
ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing
November 16, 2023 01:30 ET
|
ONWARD Medical NV
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
November 16, 2023 01:30 ET
|
ONWARD Medical NV
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 16 nov. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext: ONWD), société de technologie médicale créant des thérapies innovantes...
ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen
November 16, 2023 01:30 ET
|
ONWARD Medical NV
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, Nov. 16, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medische technologiebedrijf dat innovatieve therapieën...
ONWARD® Reports Q3 Business Update and Year-To-Date Highlights
November 16, 2023 01:30 ET
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Completing activities required for ARC-EX® FDA submission Expanded HemON Study as precursor to ARC-IM® Empower BP pivotal...